期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

儿童慢性免疫性血小板减少症的研究进展 被引量：4

Progress on juvenile chronic immune thrombocytopenic purpura
原文传递
导出
摘要 免疫性血小板减少症是儿童期较常见的出血性疾病。该文根据国际工作组共识，阐明其定义、分型标准及临床特点和诊断；就近年来关于慢性免疫性血小板减少症的发病机制，从机体免疫功能的异常、感染、血小板的凋亡机制、遗传学背景等方面进行分析，对儿童慢性免疫性血小板减少症的治疗方法进行综述。 Immune thrombocytopenic purpura is the common hemorrhagic disease in childhood. Accord-ing to the international working group consensus, the article reviews its definition, classification criteria and the clinical features and diagnosis,in regarding the pathogenesis of immune function abnormalities, infection, plate-lets apoptosis and genetic background, espeially in children＇s treatment.
作者 陆于兰(综述) 蒋慧(审校)
机构地区 上海市儿童医院上海交通大学附属儿童医院血液科 上海市嘉定区中心医院儿科
出处 《国际儿科学杂志》 2013年第3期293-296,共4页 International Journal of Pediatrics
关键词 儿童 慢性免疫性血小板减少症 综述 childhood chronic immune thrombocytopenic purpura review
分类号 R558.2 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献4

二级参考文献45

  • 1盛光耀,王璐,白松婷.骨髓TPO与TGF-β1、TGF-βRⅢ的改变及其相关性在儿童ITP发病中的意义[J].中国小儿血液,2004,9(3):99-102. 被引量：13
  • 2[1]Kuroda H,Matsunaga T,et al.Decrease of Smad4 gene expression in patients with essential thrombocythaemia may cause an escape from suppression of megakaryopoiesis by transforming growth factor-betal[J].Br J Haematol,2004,124(2):211～220.
  • 3[2]Atabay B,Oren H,et al.Role of transforming growth fac-tor-beta 1 gene polymorphisms in childhood idiopathic thrombocytopenic purpura[J].J Pediatr Hematol Oncoi,2003,25(11):885～900.
  • 4冯义,韩忠朝,等.巨核细胞扩增的研究进展[J].干细胞与再生医学,2003,2(4):106-109.
  • 5[4]Akiyama T,Matstmaga T,et al.Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis[J].Leukemia,2005,19(9):1558～66.
  • 6Cossart YE,Field AM,Cant B,et al.Parvovirus-like particles in human sera[J].Lancet,1975,1(7898):72-73.
  • 7Corcoran C,Hardie D,Yeats J,et al.Genetic variants of human parvovirus B 19 in South Africa:cocirculation of three genotypes and identification of a novel subtype of genotype 1[J].J Clin Microbiol,2010,48(1):137-142.
  • 8Chen AY,Zhang EY,Guan W,et al.The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B 19 virus infection of primary erythroid progenitor cells[J].Blood,2010,115(5):1070-1080.
  • 9Brown KE.Variants of B19[J].Dev Biol(Basel),2004,118:71-77.
  • 10Shackelton LA,Holmes EC.Phylogenetic evidence for the rapid evolution of human B19 erythrovirus[J].J Virol,2006,80(7):3666-3669.

共引文献228

同被引文献53

  • 1赵鸿鹰,王宇,赵鸿雁,徐建军,江荣科.慢性特发性血小板减少性紫癜发病机制的探讨[J].中外医疗,2008,27(23):159-160. 被引量：6
  • 2KistangariG, MccraeKR.Immune thrombocytopenia[J].Hematol Oncol Clin North Am, 2013, 27(3):495-520.
  • 3MelikeSE, BirolB, AdaletMG, et al.Childhood immune thrombocytopenia:long-term follow-up data evaluated by the criteria of the Internatio-nal Working Group on Immune Thrombocytopenic Purpura[J]. Turk J Haematol, 2014, 31(1):32-39.
  • 4Le JeuneC, BertoliS, ElhamriM, et al.Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia[J].Leuk Lymphoma, 2014, 55(4):855-862.
  • 5AhmedI, RajpurkarM, ThomasR, et al.Initial lymphocyte count and the development of persistent/chronic immune thrombocytopenic purpura[J].Pediatr Blood Cancer, 2010, 55(3):508-511.
  • 6ZhouZ, YangL, ChenZ, et al.Health-related quality of Life measured by the Short Form 36 in immune thrombocytopenic purpura:a cross-sectional survey in China[J].Eur J Haematol, 2007, 78(6):518-523.
  • 7TalaatRM, ElmaghrabyAM, BarakatSS, et al.Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP)[J].Clin Exp Immunol, 2014, 176(2):291-300.
  • 8DeelMD, KongM, CrossKP, et al.Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children[J].Pediatr Blood Cancer, 2013, 60(12):1967-1974.
  • 9Del VecchioGC, de SantisA, AccetturaL, et al.Chronic immune thrombocytopenia in childhood[J].Blood Coagul Fibrinolysis, 2014, 25(4):297-299.
  • 10Gómez-AlmaguerD, Tarín-ArzagaL, Moreno-JaimeB, et al.High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia[J].Eur J Haematol, 2013, 90(6):494-500.

引证文献4

二级引证文献27

国际儿科学杂志
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部